Breast cancer is globally the most common malignancy in women. Her2-targeted monoclonal antibodies are established treatment modalities, and vaccines are in late-stage clinical testing in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback